Page last updated: 2024-09-04

amotosalen and Neoplasms

amotosalen has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Garban, F; Heddle, NM; McCullough, J; Rebulla, P; van der Meer, PF1
Compernolle, V; Feys, HB; Van Aelst, B1
Ahmadi, M; Aspord, C; Broisat, A; Chauchet, X; Cretin, F; Genestet, C; Ghezzi, C; Laurin, D; Le Gouëllec, A; Martin, S; Plumas, J; Polack, B; Toussaint, B; Trocme, C; Verove, J; Wang, Y1

Reviews

2 review(s) available for amotosalen and Neoplasms

ArticleYear
A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets.
    Transfusion, 2020, Volume: 60, Issue:6

    Topics: Blood Platelets; Disinfection; Furocoumarins; Hematologic Diseases; Humans; Neoplasms; Platelet Transfusion; Randomized Controlled Trials as Topic; Riboflavin; Ultraviolet Rays

2020
Biomolecular Consequences of Platelet Pathogen Inactivation Methods.
    Transfusion medicine reviews, 2019, Volume: 33, Issue:1

    Topics: Blood Banks; Blood Platelets; Blood Preservation; Blood Transfusion; Furocoumarins; Hemostasis; Humans; Neoplasms; Nucleic Acids; Platelet Transfusion; Riboflavin; Signal Transduction; Thrombocytopenia; Ultraviolet Rays

2019

Other Studies

1 other study(ies) available for amotosalen and Neoplasms

ArticleYear
A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2013, Volume: 21, Issue:5

    Topics: Animals; Antigen Presentation; Antigens; Bacterial Secretion Systems; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Disease Models, Animal; Epitopes, T-Lymphocyte; Female; Furocoumarins; Humans; Immunity, Cellular; Immunotherapy; Lymphoid Tissue; Mice; Mutation; Neoplasms; Photosensitizing Agents; Pseudomonas aeruginosa; Vaccines, Attenuated; Xenograft Model Antitumor Assays

2013